Edgewise Therapeutics announced promising preclinical and early clinical results for EDG-7500, a novel cardiac drug targeting the Regulatory Light Chain to improve heart relaxation without impairing contraction. This first-in-class treatment aims to address symptomatic hypertrophic cardiomyopathy (HCM), a genetic heart disease causing thickened heart muscle and impaired relaxation. The company plans to start a Phase 3 trial in late 2026 following a successful Phase 2 trial showing safety and no significant impact on heart pumping function. A detailed scientific publication and a webcast discussion are scheduled to provide further insights into EDG-7500's mechanism and potential benefits.
Edgewise Therapeutics' cardiac drug EDG-7500 is highlighted here with Pluang's Health sector market data as context. For readers following Health stocks, as of Sep 22, 2026 17:11 WIB, 41 of 95 priced US Health-sector stocks rose and 44 fell. Notable movers include ACB at USD 3.99 with a -0.99% change and 100% buy order activity, NVAX at USD 10.31 with a -0.96% change and 98% sell order activity, and WGS at USD 97.00 with a -0.85% change and 100% buy order activity.
Zhibao Technology's reinsurance subsidiary, Zhibao Labuan Re, has approved exploring a $32 million capital injection in digital assets to strengthen its capital base. This move aims to enhance its underwriting capacity, meet regulatory solvency requi...
Gatik secured $200 million in Series D funding to grow its driverless delivery network connecting distribution centers and stores, having completed over 85,000 fully driverless orders. Meanwhile, AMD's shares surged nearly 10%, pushing its market val...
Investors shifted focus from rising interest rates to Meta's unveiling of its new Muse AI agent, which could transform enterprise technology and boost growth prospects. This AI-driven optimism helped the stock market rally, with the SPDR S&P 500 ETF ...
BlackBerry's stock surged 7% after Coretura, a joint venture of Daimler Truck and Volvo Group, chose BlackBerry's QNX-based Alloy Kore as the foundational software for its software-defined vehicle platform for commercial trucks. This marks the first ...
CME Group plans to debut Bitcoin Cash and Uniswap futures on October 19, offering both standard and Micro contract sizes for flexible trading. This move expands CME's regulated cryptocurrency derivatives lineup, which already includes Bitcoin, Ether,...
